Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8K448

Entry ID Method Resolution Chain Position Source
AF-Q8K448-F1 Predicted AlphaFoldDB

68 variants for Q8K448

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389229181 7 D>VSDG* No EVA
rs253418964 76 N>D No EVA
rs223718542 110 A>T No EVA
rs3389201341 137 Y>H No EVA
rs3402907187 178 A>H No EVA
rs266251901 188 K>E No EVA
rs3389211334 189 T>A No EVA
rs3403084127 207 E>K No EVA
rs3389225621 213 I>T No EVA
rs3389183845 228 A>G No EVA
rs3389222408 263 W>L No EVA
rs3389176194 398 I>F No EVA
rs3389217294 410 Y>* No EVA
rs3389188667 429 R>G No EVA
rs3389207427 452 E>* No EVA
rs257876817 486 S>F No EVA
rs247890896 535 D>E No EVA
rs3389176199 542 G>V No EVA
rs3389211302 553 E>* No EVA
rs3412881309 567 N>Y No EVA
rs3389217317 614 K>R No EVA
rs3402673323 716 R>S No EVA
rs3402673300 717 Y>D No EVA
rs3402787935 719 A>G No EVA
rs215325337 735 A>T No EVA
rs3389217336 775 G>V No EVA
rs3389217549 808 E>K No EVA
rs238241721 833 S>L No EVA
rs3389213775 835 S>C No EVA
rs3389222444 843 Q>P No EVA
rs3389201275 844 V>M No EVA
rs242867532 850 F>L No EVA
rs253648424 930 E>D No EVA
rs3389207441 957 L>F No EVA
rs3401538658 970 A>G No EVA
rs3402858958 972 F>L No EVA
rs3402673265 972 F>V No EVA
rs3402539226 972 F>Y No EVA
rs3389188609 974 S>C No EVA
rs3389207505 991 Y>H No EVA
rs251948956 1000 A>V No EVA
rs3389225676 1013 T>I No EVA
rs242096210 1019 I>V No EVA
rs3389214808 1178 P>R No EVA
rs3389217352 1200 T>I No EVA
rs27019251 1231 I>K No EVA
rs3389213701 1245 A>V No EVA
rs3389229157 1254 K>N No EVA
rs3389214774 1273 L>V No EVA
rs3389229159 1294 N>K No EVA
rs3389183851 1303 K>Q No EVA
rs3389225661 1331 L>M No EVA
rs3389229177 1340 S>G No EVA
rs237712782 1345 T>I No EVA
rs3389201266 1379 C>S No EVA
rs3389176165 1421 D>V No EVA
rs3402107323 1466 R>S No EVA
rs3402959297 1469 Q>R No EVA
rs3389207514 1496 A>T No EVA
rs3402959298 1498 A>P No EVA
rs3402107262 1499 V>L No EVA
rs3389222410 1600 F>L No EVA
rs3389216312 1601 S>P No EVA
rs3402539218 1612 L>V No EVA
rs3403083246 1616 Q>* No EVA
rs3402794653 1617 E>K No EVA
rs27019276 1626 L>V No EVA
rs49661564 1636 Q>H No EVA

No associated diseases with Q8K448

6 regional properties for Q8K448

Type Name Position InterPro Accession
domain ABC transporter-like, ATP-binding domain 478 - 713 IPR003439-1
domain ABC transporter-like, ATP-binding domain 1290 - 1533 IPR003439-2
domain AAA+ ATPase domain 506 - 691 IPR003593-1
domain AAA+ ATPase domain 1325 - 1512 IPR003593-2
domain ABC-2 type transporter, transmembrane domain 33 - 416 IPR013525
conserved_site ABC transporter-like, conserved site 615 - 629 IPR017871

Functions

Description
EC Number
Subcellular Localization
  • Golgi apparatus membrane ; Multi-pass membrane protein
  • Lysosome membrane ; Multi-pass membrane protein
  • Late endosome membrane ; Multi-pass membrane protein
  • Cell membrane
  • Localized at cell membrane under high cholesterol levels
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi membrane The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
intracellular membrane-bounded organelle Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
late endosome A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.
late endosome membrane The lipid bilayer surrounding a late endosome.
lysosomal membrane The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
lysosome A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

4 GO annotations of molecular function

Name Definition
ABC-type transporter activity Primary active transporter characterized by two nucleotide-binding domains and two transmembrane domains. Uses the energy generated from ATP hydrolysis to drive the transport of a substance across a membrane.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATPase-coupled transmembrane transporter activity Primary active transporter of a solute across a membrane, via the reaction: ATP + H2O = ADP + phosphate, to directly drive the transport of a substance across a membrane. The transport protein may be transiently phosphorylated (P-type transporters), or not (ABC-type transporters and other families of transporters). Primary active transport occurs up the solute's concentration gradient and is driven by a primary energy source.
lipid transporter activity Enables the directed movement of lipids into, out of or within a cell, or between cells.

9 GO annotations of biological process

Name Definition
cholesterol efflux The directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
cholesterol homeostasis Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell.
cholesterol metabolic process The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues.
high-density lipoprotein particle remodeling The acquisition, loss or modification of a protein or lipid within a high-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.
lipid transport The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
negative regulation of macrophage derived foam cell differentiation Any process that decreases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.
positive regulation of reverse cholesterol transport Any process that activates or increases the frequency, rate or extent of reverse cholesterol transport.
regulation of cholesterol efflux Any process that modulates the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
reverse cholesterol transport The directed movement of peripheral cell cholesterol, cholest-5-en-3-beta-ol, towards the liver for catabolism.

12 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q86UK0 ABCA12 Glucosylceramide transporter ABCA12 Homo sapiens (Human) PR
P78363 ABCA4 Retinal-specific phospholipid-transporting ATPase ABCA4 Homo sapiens (Human) PR
Q8IUA7 ABCA9 ATP-binding cassette sub-family A member 9 Homo sapiens (Human) PR
Q8N139 ABCA6 ATP-binding cassette sub-family A member 6 Homo sapiens (Human) PR
Q8WWZ4 ABCA10 ATP-binding cassette sub-family A member 10 Homo sapiens (Human) PR
Q8WWZ7 ABCA5 Cholesterol transporter ABCA5 Homo sapiens (Human) PR
Q8K442 Abca8a ABC-type organic anion transporter ABCA8A Mus musculus (Mouse) PR
Q8K449 Abca9 ATP-binding cassette sub-family A member 9 Mus musculus (Mouse) PR
P34358 ced-7 ABC transporter ced-7 Caenorhabditis elegans PR
Q84K47 ABCA2 ABC transporter A family member 2 Arabidopsis thaliana (Mouse-ear cress) PR
Q9FKF2 ABCA11 ABC transporter A family member 11 Arabidopsis thaliana (Mouse-ear cress) PR
Q9FLT5 ABCA9 ABC transporter A family member 9 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MATAIRDVGV WRQTRTLLLK NYLIKCRTKK SSVQEILFPL FFLFWLILVS MMHPNKKYEE
70 80 90 100 110 120
VSDIELSPMD KFSLSNVILG YTPVTNITSS IMQRVSTDHL PKVIVTEEYA NEKELVAASL
130 140 150 160 170 180
SKSSNFVGVV FKDTMSYELR FFPEMIPVSS IYMNSREGCS KTCDAAQYWS LGFTVLQASI
190 200 210 220 230 240
DAAIIQLKTN VSVWSELEST KAVIMGEAAV VEIDTFPRGV ILIYLVIAFS PFGYFLAIHI
250 260 270 280 290 300
VAEKEKKLKE FLKIMGLHDT AFWLSWVLLY ASLIFLMSLL MAVIATASSL FPQSSSIVIF
310 320 330 340 350 360
LLFFLYGLSS VFFALMLTPL FKKSKHVGVV EFFVTVVFGF VGLLIVLIES FPRSLVWLFS
370 380 390 400 410 420
PLCQCAFLIG IAQVMHLEDF NEGALFSNLT EGPYPLIITI IMLALDSVFY VLLAVYLDQV
430 440 450 460 470 480
IPGEFGLRRS SLYFLKPSYW SKNKRNYKEL SEGNINGNIS LNEIVEPVSS EFIGKEAIRI
490 500 510 520 530 540
SGIQKSYRKK TENVEALRNL SFDIYEGQIT ALLGHSGTGK STLMNILCGL CPPSDGFASI
550 560 570 580 590 600
YGHRVSEIDE MFEARKMIGI CPQSDINFDV LTVEENLSIL ASIKGIPANN IIQEVQKVLL
610 620 630 640 650 660
DLDMQAIKDN QAKKLSGGQK RKLSVGIAVL GNPKILLLDE PTAGMDPCSR HIVWNLLKYR
670 680 690 700 710 720
KANRVTVFST HFMDEADILA DRKAVISQGM LKCVGSSIFL KSKWGIGYRL SMYIDRYCAT
730 740 750 760 770 780
ESLSSLVRQH IPAAALLQQN DQQLVYSLPF KDMDKFSGLF SALDIHSNLG VISYGVSMTT
790 800 810 820 830 840
LEDVFLKLEV EAEIDQADYS VFTQQPREEE TDSKSFDEME QSLLILSETK ASSVSTMSLW
850 860 870 880 890 900
KQQVSTIAKF HFLSLKRESK SVRAVLLLLL IFFAVQIFMF FLHHSFKNAV VPIKLVPDLY
910 920 930 940 950 960
FLKPGDKPHK YKTSLLLQNS TDSDINGLIE FFAHQNIMVA MFNDSDYVSA APHSAALNVV
970 980 990 1000 1010 1020
RSEKDYVFSA VFNSTMVYCL PVMMNIISNY YLYHLNVTEA IQTWSTPFIQ EITDIVFKIE
1030 1040 1050 1060 1070 1080
LYFQAALLGI IVTAMPPYFA MENAENHKIK AYTQLKLSGL LPSAYWVGQA VVDIPLFFVV
1090 1100 1110 1120 1130 1140
LILMLGSLFA FHHGLYFYPA KFLAVVFCLI AYVPSVILFT YIASFTFKKI LNTKEFWSFI
1150 1160 1170 1180 1190 1200
YSVTALACVA ITETTFFLQY AVTAVFHYTF CIAIPIYPLL GCLISFIKGS WKNMPKNENT
1210 1220 1230 1240 1250 1260
YNPWDRLLVA VIMPYLQCIL WIFLLQHYEK IHGGRSIRKD PFFRALSQKA KNKKFPEPPI
1270 1280 1290 1300 1310 1320
NEDEDEDVKA ERLKVKELMG CQCCEEKPAI MVCNLHKEYD DKKDFLHSRK TTKVATKYIS
1330 1340 1350 1360 1370 1380
FCVKKGEILG LLGPNGAGKS TVINTLVGDV EPTSGKIFLG DYGSHSSEDD ESIKCMGYCP
1390 1400 1410 1420 1430 1440
QTNPLWPDLT LQEHFEIYGA VKGMSPGDMK EVISRITKAL DLKEHLQKTV KKLPAGIKRK
1450 1460 1470 1480 1490 1500
LCFALSMLGN PQVTLLDEPS TGMDPRAKQH MWRAIRTAFK NKKRAALLTT HYMEEAEAVC
1510 1520 1530 1540 1550 1560
DRVAIMVSGQ LRCIGTVQHL KSKFGKGYFL EIKLKDWIEN LEIDRLQREI QYIFPNASRQ
1570 1580 1590 1600 1610 1620
ESFSSILAFK IPKEDVQSLS QSFAKLEEAK RTFAIEEYSF SQATLEQVFV ELTKEQEEED
1630 1640
NSCGTLASTL WWERTQEDRV VF